Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Case Study: YourChoice Therapeutics
Download7 - 12 of 246 results
Generation of frameshift‑mutated TGFβR2‑specific T cells in healthy volunteers in a phase 1 study
17 June 2026Randomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, an inhaled TMEM16A potentiator
17 June 2026Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro Biotransformation
17 June 2026Phase-1 MAD study to evaluate GDC-6988, a dry powder formulation of a selective inhaled potentiator of TMEM16A
17 June 2026Case Study: YourChoice Therapeutics
15 June 2026Using PBPK modelling to identify physiological changes induced by CLF065, a GLP 2 receptor agonist
12 June 2026Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.